Thema: US6951271005
PCRX, US6951271005
chart-840333_1920.jpg - Foto: THN
Pacira BioSciences stock: H.C. Wainwright cuts target to USD 36.50
Pacira BioSciences stock remains shaped by the announced Viatris deal and a more cautious analyst view. Exparel growth is a key concern.
ad-hoc-news.de, heute 01:59 Uhr
PCRX, US6951271005
HC Wainwright cuts target for Pacira BioSciences stock to ...
Q2 revenue reached USD 192.40 million. Pacira BioSciences stock costs EUR 32.30 on October 20, 2026, up 0.94 percent versus the Frankfurt close.
ad-hoc-news.de, 20.10.26 22:04 Uhr
PCRX, US6951271005
Pacira BioSciences stock at USD 36.34 on October 16 2026 ...
Second-quarter revenue was USD 192.40 million. Pacira BioSciences stock was last at USD 36.34 on October 16, 2026, up 0.03 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 21:23 Uhr
PCRX, US6951271005
Royal Bank of Canada lifts target for Pacira BioSciences ...
Revenue in the second quarter was USD 192.40 million, up 6.20 percent. Pacira BioSciences stock costs EUR 32.50 on October 15, 2026.
ad-hoc-news.de, 15.10.26 19:03 Uhr
PCRX, US6951271005
Pacira BioSciences stock falls 2.35 percent to USD 24.11 ...
Pacira BioSciences stock closed at USD 24.11 on September 21, 2026, down 2.35 percent from the prior close. Market value stood at USD 961.07 million.
ad-hoc-news.de, 22.09.26 11:09 Uhr
Pacira, BioSciences
Pacira BioSciences Demonstrates Sustained Momentum with ...
Pacira US6951271005
boerse-global.de, 06.02.26 20:01 Uhr
Pacira, Shares
Pacira Shares Show Promise Amidst Lingering Challenges
